Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT)

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Reyngold, Marsha ^a   Wu, Abraham J ^a   McLane, Amanda ^a   Zhang, Zhigang ^b   Hsu, Meier ^b   Stein, Nicholas F ^a   Zhou, Ying ^a   Ho, Alice Y ^a   Rosenzweig, Kenneth E ^c   Yorke, Ellen D ^a   Rimner, Andreas ^a  

^a Memorial Sloan Kettering ^*  (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

BED; Lung re irradiation; Pulmonary toxicity; SBRT

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BRACHIAL PLEXOPATHY; BRACHIAL PLEXUS NEUROPATHY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPNEA; ESOPHAGUS INJURY; ESOPHAGUS TOXICITY; FATIGUE; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; IMAGE GUIDED RADIOTHERAPY; LOCAL PROGRESSION FREE SURVIVAL; LUNG CANCER; LUNG METASTASIS; LUNG TOXICITY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PATIENT SAFETY; PROGRESSION FREE SURVIVAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RECURRENCE FREE SURVIVAL; SKIN TOXICITY; STEREOTACTIC BODY RADIATION THERAPY; THORACIC REIRRADIATION; THORAX PAIN; THORAX SURGERY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; RADIOTHERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; THORAX; TREATMENT OUTCOME;

EID: 84876966705     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-99     Document Type: Article

References (27)

1. Tyldesley S, Boyd C, Schulze K, Walker H, Mackillop WJ. Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach. Int J Radiat Oncol Biol Phys 2001, 49:973-985. 10.1016/S0360-3016(00)01401-2, 11240238.
2. Jeremic B, Shibamoto Y, Acimovic L, Nikolic N, Dagovic A, Aleksandrovic J, Radosavljevic-Asic G. Second cancers occurring in patients with early stage non-small-cell lung cancer treated with chest radiation therapy alone. J Clin Oncol 2001, 19:1056-1063.
3. Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, Ginsberg RJ. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995, 109:120-129. 10.1016/S0022-5223(95)70427-2, 7815787.
4. Carr SR, Schuchert MJ, Pennathur A, Wilson DO, Siegfried JM, Luketich JD, Landreneau RJ. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system. J Thorac Cardiovasc Surg 2012, 143:390-397. 10.1016/j.jtcvs.2011.10.023, 22169444.
5. Curran WJ, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst 2011, 103:1452-1460. 10.1093/jnci/djr325, 3186782, 21903745.
6. Wu KL, Jiang GL, Qian H, Wang LJ, Yang HJ, Fu XL, Zhao S. Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: a prospective phase I-II clinical trial. Int J Radiat Oncol Biol Phys 2003, 57:1345-1350. 10.1016/S0360-3016(03)00768-5, 14630272.
7. Tada T, Fukuda H, Matsui K, Hirashima T, Hosono M, Takada Y, Inoue Y. Non-small-cell lung cancer: reirradiation for loco-regional relapse previously treated with radiation therapy. Int J Clin Oncol 2005, 10:247-250. 10.1007/s10147-005-0501-1, 16136369.
8. Okamoto Y, Murakami M, Yoden E, Sasaki R, Okuno Y, Nakajima T, Kuroda Y. Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. Int J Radiat Oncol Biol Phys 2002, 52:390-396. 10.1016/S0360-3016(01)02644-X, 11872284.
9. Green N, Melbye RW. Lung cancer: retreatment of local recurrence after definitive irradiation. Cancer 1982, 49:865-868. 10.1002/1097-0142(19820301)49:5<865::AID-CNCR2820490507>3.0.CO;2-H, 7059924.
10. Montebello JF, Aron BS, Manatunga AK, Horvath JL, Peyton FW. The reirradiation of recurrent bronchogenic carcinoma with external beam irradiation. Am J Clin Oncol 1993, 16:482-488. 10.1097/00000421-199312000-00004, 8256761.
11. Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K, Yamashita T, Niibe Y, Karasawa K, Hayakawa K. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004, 101:1623-1631. 10.1002/cncr.20539, 15378503.
12. Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303:1070-1076. 10.1001/jama.2010.261, 2907644, 20233825.
13. Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, Pugh TJ, Kane M, Gaspar LE, Schefter TE. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009, 27:1579-1584. 10.1200/JCO.2008.19.6386, 19255320.
14. Le QT, Loo BW, Ho A, Cotrutz C, Koong AC, Wakelee H, Kee ST, Constantinescu D, Whyte RI, Donington J. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol 2006, 1:802-809. 10.1097/01243894-200610000-00008, 17409963.
15. Ernst-Stecken A, Lambrecht U, Mueller R, Sauer R, Grabenbauer G. Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: first results of a phase I/II study. Strahlenther Onkol 2006, 182:696-702. 10.1007/s00066-006-1577-x, 3233368, 17149575.
16. Kelly P, Balter PA, Rebueno N, Sharp HJ, Liao Z, Komaki R, Chang JY. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Int J Radiat Oncol Biol Phys 2010, 78:1387-1393. 10.1016/j.ijrobp.2009.09.070, 3401019, 20381271.
17. Liu H, Zhang X, Vinogradskiy YY, Swisher SG, Komaki R, Chang JY. Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy. Int J Radiat Oncol Biol Phys 2012, 84:1017-1023. 10.1016/j.ijrobp.2012.02.020, 3612879, 22543216.
18. Trakul N, Harris JP, Le QT, Hara WY, Maxim PG, Loo BW, Diehn M. Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors. J Thorac Oncol 2012, 7:1462-1465. 10.1097/JTO.0b013e31825f22ce, 22895143.
19. Mohan R, Barest G, Brewster LJ, Chui CS, Kutcher GJ, Laughlin JS, Fuks Z. A comprehensive three-dimensional radiation treatment planning system. Int J Radiat Oncol Biol Phys 1988, 15:481-495. 10.1016/S0360-3016(98)90033-5, 3403328.
20. Chui CS, LoSasso T, Spirou S. Dose calculation for photon beams with intensity modulation generated by dynamic jaw or multileaf collimations. Med Phys 1994, 21:1237-1244. 10.1118/1.597206, 7799865.
21. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975, 70:606-612.
22. Hoppe BS, Laser B, Kowalski AV, Fontenla SC, Pena-Greenberg E, Yorke ED, Lovelock DM, Hunt MA, Rosenzweig KE. Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk?. Int J Radiat Oncol Biol Phys 2008, 72:1283-1286. 10.1016/j.ijrobp.2008.08.036, 19028267.
23. Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, Timmerman R. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009, 75:677-682. 10.1016/j.ijrobp.2008.11.042, 19251380.
24. Uematsu M, Shioda A, Suda A, Fukui T, Ozeki Y, Hama Y, Wong JR, Kusano S. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 2001, 51:666-670. 10.1016/S0360-3016(01)01703-5, 11597807.
25. Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, Sakamoto M, Mitsumori M, Shibuya K, Araki N. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005, 63:1427-1431. 10.1016/j.ijrobp.2005.05.034, 16169670.
26. Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, Drugge N, Ekberg L, Friesland S, Johansson KA. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009, 27:3290-3296. 10.1200/JCO.2008.21.5681, 19414667.
27. Norihisa Y, Nagata Y, Takayama K, Matsuo Y, Sakamoto T, Sakamoto M, Mizowaki T, Yano S, Hiraoka M. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 2008, 72:398-403. 10.1016/j.ijrobp.2008.01.002, 18374506.